As of October 2023, Christine Leopold is an Assistant Professor of Drug Regulatory Science at the Division of Pharmacoepidemiology & Clinical Pharmacology at Utrecht Institute for Pharmaceutical Science / WHO Collaborating Centre for Pharmaceutical Policy and Regulation.

Prior to her appointment at Utrecht, she worked as a Senior Consultant at Triangulate Health Ltd, where she led various investment cases on air pollution, AMR and tobacco cessation for different UN-agencies.

From 2014 to 2018, Dr. Leopold was a Senior Research Fellow in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute, Division of Health Policy and Insurance Research. Her research focused on providing evidence on access to and affordability of medicines by examining the economic burden of cancer treatments, by comparing countries’ medicine pricing and reimbursement policies and by assessing patients’ and providers’ perceptions on value measures in cancer care.

Prior to joining the Department of Population Medicine, she worked as a senior researcher at the Austrian Public Health Institute, Department of Health Economics / WHO Collaborating Center for Pharmaceutical Pricing and Reimbursement Policies, where she co-led the Austrian Centre for Rare Diseases as well as the European Network of public authorities of Pharmaceutical Pricing and Reimbursement Information (PPRI).  
 
She holds a doctorate in Pharmaceutical Policy from Utrecht University, Utrecht Institute for Pharmaceutical Science / WHO Collaborating Centre for Pharmaceutical Policy and Regulation, a Master of International Health Care Management, Economics and Politics from Bocconi University (Italy) and a Master of International Business Relations from the University of Applied Science (Austria).